Hubei Guangji Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 176.325 million compared to CNY 133.421 million a year ago. Operating income was CNY 17.897 million compared to operating loss of CNY 13.297 million a year ago. Net income was CNY 13.838 million compared to net loss of CNY 13.243 million a year ago. Basic earnings per share from continuing operations was CNY 0.0556 compared to basic loss per share from continuing operations of CNY 0.0433 a year ago.